Correlation Between Ceapro and Nascent Biotech
Can any of the company-specific risk be diversified away by investing in both Ceapro and Nascent Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ceapro and Nascent Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ceapro Inc and Nascent Biotech, you can compare the effects of market volatilities on Ceapro and Nascent Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ceapro with a short position of Nascent Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ceapro and Nascent Biotech.
Diversification Opportunities for Ceapro and Nascent Biotech
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Ceapro and Nascent is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ceapro Inc and Nascent Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nascent Biotech and Ceapro is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ceapro Inc are associated (or correlated) with Nascent Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nascent Biotech has no effect on the direction of Ceapro i.e., Ceapro and Nascent Biotech go up and down completely randomly.
Pair Corralation between Ceapro and Nascent Biotech
If you would invest 6.20 in Nascent Biotech on December 3, 2024 and sell it today you would lose (5.45) from holding Nascent Biotech or give up 87.9% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Ceapro Inc vs. Nascent Biotech
Performance |
Timeline |
Ceapro Inc |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Nascent Biotech |
Ceapro and Nascent Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ceapro and Nascent Biotech
The main advantage of trading using opposite Ceapro and Nascent Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ceapro position performs unexpectedly, Nascent Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nascent Biotech will offset losses from the drop in Nascent Biotech's long position.Ceapro vs. Biotron Limited | Ceapro vs. biOasis Technologies | Ceapro vs. Covalon Technologies | Ceapro vs. Mosaic Immunoengineering |
Nascent Biotech vs. Protokinetix | Nascent Biotech vs. Silo Pharma | Nascent Biotech vs. Vg Life Sciences | Nascent Biotech vs. Mymetics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |